CLINICAL_TRIALS
trial_result
· 2021-10-22
Clinical Trial Update: Management of Popeye Sign With Botulinum Toxin After Bicepstenotomy [Phase 4]
Summary
A Phase 4 clinical trial evaluating the management of Popeye sign using botulinum toxin after biceps tenotomy is ongoing with undisclosed status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AZ Delta | Conditions: Popeye Syndrome | Phase 4 | Status: UNKNOWN